nach oben

International Journal of Clinical Oncology

Erschienen in:

01.02.2013 | Original Article

Computed tomography fluoroscopy-guided radiofrequency ablation following intra-arterial iodized-oil injection for hepatocellular carcinomas invisible on ultrasonographic images

verfasst von: Haruyuki Takaki, Koichiro Yamakado, Atsuhiro Nakatsuka, Tomomi Yamada, Junji Uraki, Masataka Kashima, Takashi Yamanaka, Katsuya Shiraki, Yoshiyuki Takei, Kan Takeda

Erschienen in: International Journal of Clinical Oncology | Ausgabe 1/2013

Einloggen, um Zugang zu erhalten

Abstract

Background

We aimed to evaluate therapeutic outcomes of radiofrequency (RF) ablation following intra-arterial iodized-oil injection for hepatocellular carcinomas (HCCs) invisible on ultrasonographic (US) images.

Materials and methods

Informed consent was waived for this retrospective study approved by our institutional review board. Sixty-seven consecutive patients with 150 HCCs (mean diameter 1.3 ± 0.6 cm; range 0.5–4.2 cm) received 90 RF sessions following intra-arterial iodized-oil injection. Each patient had at least one HCC invisible on US images. Computed tomography (CT) fluoroscopy-guided RF ablation was performed within 1 week after the injection of iodized oil from feeding arteries of each tumor. Technical success was defined as a planned electrode placement and completion of ablation protocol. Technical success, complications, changes in liver function, local tumor progression, and survival were evaluated.

Results

All HCCs became visible on CT fluoroscopy after iodized-oil injection, and RF ablation was technically successful in all sessions (technical success rate, 100%, 90/90). Major complications occurred in 6 RF sessions (6.7%, 6/90), including hemorrhage (2.2%, 2/90), portal thrombosis (2.2%, 2/90), and pneumothorax (2.2%, 2/90). No significant deterioration in Child–Pugh score was found. The mean follow-up period was 23.2 ± 18.0 months. The cumulative local tumor progression rates and overall survival rates were, respectively, 3.9 and 82.7% at 1 year, 5.3 and 45.3% at 3 years, and 5.3 and 26.4% at 5 years.

Conclusion

CT fluoroscopy-guided RF ablation following intra-arterial iodized-oil injection is a feasible, safe, and useful therapeutic option for HCCs invisible on US images.

Llovet JM, Bruix J (2008) Novel advancements in the management of hepatocellular carcinoma in 2008. J Hepatol 48:20–37CrossRef

Shiina S (2009) Image-guided percutaneous ablation therapies for hepatocellular carcinoma. J Gastroenterol 44:122–131PubMedCrossRef

Choi D, Lim HK, Rhim H et al (2007) Percutaneous radiofrequency ablation for early stage hepatocellular carcinoma as a first-line treatment: long-term results and prognostic factors in a large single-institution series. Eur Radiol 17:684–692PubMedCrossRef

Tateishi R, Shiina S, Teratani T et al (2005) Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1000 cases. Cancer 103:1201–1209PubMedCrossRef

Lecioni R, Cioni D, Crocetti L et al (2005) Early stage hepatocellular carcinoma in patients with cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation. Radiology 234:961–967CrossRef

Rhim H, Lee MH, Kim YS et al (2008) Planning sonography to assess the feasibility of percutaneous radiofrequency ablation of hepatocellular carcinomas. AJR 190:1324–1330PubMedCrossRef

Park BJ, Byun JH, Jin YH et al (2009) CT-guided radiofrequency ablation for hepatocellular carcinomas that were undetectable at US: therapeutic effectiveness and safety. J Vasc Interv Radiol 20:490–499PubMedCrossRef

Shibata T, Shibata T, Maetani Y et al (2004) Transthoracic percutaneous radiofrequency ablation for liver tumors in the hepatic dome. J Vasc Interv Radiol 15:1323–1327PubMedCrossRef

Gandhi S, Iannitti DA, Mayo-Smith WW et al (2006) Technical report: lipiodol-guided computed tomography for radiofrequency ablation of hepatocellular carcinoma. Clin Radiol 61:888–891PubMedCrossRef

10.

Kurokohchi K, Deguchi A, Masaki T et al (2007) Successful treatment of hypovascular advanced hepatocellular carcinoma with lipiodol-targeting intervention radiology. World J Gastroenterol 13:4398–4400PubMed

11.

Bruix J, Sherman M, Llovet JM et al (2001) Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 35:421–430PubMedCrossRef

12.

Goldberg SN, Grassi CJ, Cardella JF et al (2005) Image-guided tumor ablation: standardization of terminology and reporting criteria. Radiology 235:728–739PubMedCrossRef

13.

Sacks D, McClenny TE, Cardella JF et al (2003) Society of Interventional Radiology clinical practice guidelines. J Vasc Interv Radiol 14:199–202CrossRef

14.

Koda M, Ueki M, Maeda Y et al (2004) Percutaneous sonographically guided radiofrequency ablation with artificial pleural effusion for hepatocellular carcinoma located under the diaphragm. AJR 183:583–588PubMed

15.

Rhim H, Lim HK, Kim YS et al (2008) Percutaneous radiofrequency ablation with artificial ascites for hepatocellular carcinoma in the hepatic dome: initial experience. AJR 190:91–98PubMedCrossRef

16.

Miyamoto N, Hiramatsu K, Tsuchiya K et al (2009) Sonazoid-enhanced sonography for guiding radiofrequency ablation for hepatocellular carcinoma: better tumor visualization by Kupffer-phase imaging and vascular-phase imaging after reinjection. Jpn J Radiol 27:185–193PubMedCrossRef

17.

Krücker J, Xu S, Glossop N et al (2007) Electromagnetic tracking for thermal ablation and biopsy guidance: clinical evaluation of spatial accuracy. J Vasc Interv Radiol 18:1141–1150PubMedCrossRef

18.

Takaki H, Yamakado K, Nakatsuka A et al (2007) Radiofrequency ablation combined with chemoembolization for the treatment of hepatocellular carcinomas 5 cm or smaller: risk factors for local tumor progression. J Vasc Interv Radiol 18:856–861PubMedCrossRef

19.

Yamakado K, Nakatsuka A, Ohmori S et al (2002) Radiofrequency ablation combined with chemoembolization in hepatocellular carcinoma: treatment response based on tumor size and morphology. J Vasc Interv Radiol 13:1225–1232PubMedCrossRef

20.

Sugimori K, Nozawa A, Morimoto M et al (2005) Extension of radiofrequency ablation of the liver by transcatheter arterial embolization with iodized oil and gelatin sponge: results in a pig model. J Vasc Interv Radiol 16:849–856PubMedCrossRef

21.

Kang SG, Yoon CJ, Jeong SH et al (2009) Single-session combined therapy with chemoembolization and radiofrequency ablation in hepatocellular carcinoma less than or equal to 5 cm: a preliminary study. J Vasc Interv Radiol 20:1570–1577PubMedCrossRef

22.

Livraghi T, Solbiati L, Meloni MF et al (2003) Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study. Radiology 226:441–451PubMedCrossRef

23.

de Baère T, Risse O, Kuoch V et al (2003) Adverse events during radiofrequency treatment of 582 hepatic tumors. AJR 181:695–700PubMed

24.

Kong WT, Zang WW, Qiu YD et al (2009) Major complications after radiofrequency ablation for liver tumors: analysis of 255 patients. World J Gastroenterol 15:2651–2656PubMedCrossRef

25.

Yamakado K, Nakatsuka A, Takaki H et al (2010) Subphrenic versus nonsubphrenic hepatocellular carcinoma: combined therapy with chemoembolization and radiofrequency ablation. AJR 194:530–535PubMedCrossRef

Titel: Computed tomography fluoroscopy-guided radiofrequency ablation following intra-arterial iodized-oil injection for hepatocellular carcinomas invisible on ultrasonographic images
verfasst von: Haruyuki Takaki
Koichiro Yamakado
Atsuhiro Nakatsuka
Tomomi Yamada
Junji Uraki
Masataka Kashima
Takashi Yamanaka
Katsuya Shiraki
Yoshiyuki Takei
Kan Takeda
Publikationsdatum: 01.02.2013
Verlag: Springer Japan
Erschienen in: International Journal of Clinical Oncology / Ausgabe 1/2013
Print ISSN: 1341-9625
Elektronische ISSN: 1437-7772
DOI: https://doi.org/10.1007/s10147-011-0340-1

Springer Medizin

Computed tomography fluoroscopy-guided radiofrequency ablation following intra-arterial iodized-oil injection for hepatocellular carcinomas invisible on ultrasonographic images